Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rockwell Medical (RMTI) Change in Acquisitions & Divestments (2016 - 2025)

Rockwell Medical (RMTI) has disclosed Change in Acquisitions & Divestments for 10 consecutive years, with $3.0 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Change in Acquisitions & Divestments changed N/A year-over-year to $3.0 million, compared with a TTM value of $9.0 million through Sep 2025, up 49.93%, and an annual FY2024 reading of $2.0 million, down 86.91% over the prior year.
  • Change in Acquisitions & Divestments was $3.0 million for Q3 2025 at Rockwell Medical, roughly flat from $3.0 million in the prior quarter.
  • Across five years, Change in Acquisitions & Divestments topped out at $12.0 million in Q1 2022 and bottomed at $1.8 million in Q2 2023.
  • Average Change in Acquisitions & Divestments over 5 years is $5.2 million, with a median of $4.1 million recorded in 2021.
  • The sharpest move saw Change in Acquisitions & Divestments crashed 57.15% in 2021, then skyrocketed 77.68% in 2022.
  • Year by year, Change in Acquisitions & Divestments stood at $7.6 million in 2021, then decreased by 5.19% to $7.2 million in 2022, then tumbled by 44.52% to $4.0 million in 2023, then plummeted by 49.92% to $2.0 million in 2024, then surged by 49.78% to $3.0 million in 2025.
  • Business Quant data shows Change in Acquisitions & Divestments for RMTI at $3.0 million in Q3 2025, $3.0 million in Q2 2025, and $3.0 million in Q1 2025.